483 Response Bloodworks Feb 2013

Alexander Kay FDA, Stephen Souza FDA, Dianna Wardlow-Dotter FDA$119.00 - Available Now

FDA investigators audited the Bloodworks - Seattle, WA, United States facility and issued inspectional observation (via FDA 483) on 15 Feb 2013.

Product details

  • Category:
  • Inspection end: 15 Feb 2013
  • Location: Seattle, United States
  • FEI: 3071347
Add To Cart